Cargando…

Enhancement of Antiviral CD8(+) T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab

Background: Pembrolizumab is an immune checkpoint inhibitor against programmed cell death protein-1 (PD-1) approved for therapy in metastatic melanoma. PD-1 expression is associated with a diminished functionality in HIV-1 specific-CD8(+) T cells. It is thought that PD-1 blockade could contribute to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanch-Lombarte, Oscar, Gálvez, Cristina, Revollo, Boris, Jiménez-Moyano, Esther, Llibre, Josep M., Manzano, José Luís, Boada, Aram, Dalmau, Judith, E. Speiser, Daniel, Clotet, Bonaventura, G. Prado, Julia, Martinez-Picado, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947580/ https://www.ncbi.nlm.nih.gov/pubmed/31805700 http://dx.doi.org/10.3390/jcm8122089

Ejemplares similares

Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors
por: Codoñer, Francisco M, et al.
Publicado: (2017)

HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy
por: Blanch-Lombarte, Oscar, et al.
Publicado: (2020)

Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells
por: Ruiz, Alba, et al.
Publicado: (2019)

Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART
por: Blanch-Lombarte, Oscar, et al.
Publicado: (2023)

Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses
por: Salgado, Maria, et al.
Publicado: (2018)

Antigen-detecting rapid tests or real-time PCR, what test to use and why?()
por: Revollo Barriga, Boris, et al.
Publicado: (2021)

Test rápidos antigénicos o PCR en tiempo real para SARS-CoV-2, ¿qué test usar y por qué?
por: Revollo Barriga, Boris, et al.
Publicado: (2021)

Practical measures for SARS-CoV-2 infection prevention – Authors' reply
por: Llibre, Josep M, et al.
Publicado: (2022)

Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
por: Larsen, Frederik Uttenthal, et al.
Publicado: (2019)

Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors
por: Colomer-Lluch, Marta, et al.
Publicado: (2022)

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy
por: Bernal, Silvia, et al.
Publicado: (2023)

In–Depth Characterization of Viral Isolates from Plasma and Cells Compared with Plasma Circulating Quasispecies in Early HIV-1 Infection
por: Dalmau, Judith, et al.
Publicado: (2012)

Use of antiviral drugs to reduce COVID-19 transmission
por: Mitjà, Oriol, et al.
Publicado: (2020)

Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART
por: Buzón, Maria J., et al.
Publicado: (2011)

Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial
por: Revollo, Boris, et al.
Publicado: (2021)

Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors
por: Kilpeläinen, Athina, et al.
Publicado: (2022)

Impact of Mass Workplace COVID-19 Rapid Testing on Health and Healthcare Resource Savings
por: López Seguí, Francesc, et al.
Publicado: (2021)

Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?
por: España Fernandez, Sofia, et al.
Publicado: (2023)

Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men
por: Vela, Sandra, et al.
Publicado: (2018)

Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)
por: Gonzalez-Cao, Maria, et al.
Publicado: (2021)

Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy
por: Gálvez, Cristina, et al.
Publicado: (2021)

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
por: Llibre, Josep M, et al.
Publicado: (2013)

Hidden costs of antiretroviral treatment: the public health efficiency of drug packaging
por: Andreu-Crespo, Àngels, et al.
Publicado: (2015)

Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
por: Santos, José R., et al.
Publicado: (2012)

Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging
por: Llibre-Codina, Josep M, et al.
Publicado: (2014)

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia
por: Llibre, Josep M., et al.
Publicado: (2015)

SAT-661 The Lesser Evil: Pembrolizumab Induced Remission of Metastatic Melanoma with Autoimmune Diabetes, Hypothyroidism, and Colitis
por: Harris, Asaf, et al.
Publicado: (2020)

Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
por: Satish, Tejus, et al.
Publicado: (2021)

Erratum for Puertas et al., “VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies”
por: Puertas, Maria C., et al.
Publicado: (2021)

VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies
por: Puertas, Maria C., et al.
Publicado: (2021)

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab
por: Wang, Wei Cen, et al.
Publicado: (2023)

Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals
por: Massanella, Marta, et al.
Publicado: (2014)

Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control
por: Oriol-Tordera, Bruna, et al.
Publicado: (2020)

Altered T‐cell subset distribution in the viral reservoir in HIV‐1‐infected individuals with extremely low proviral DNA (LoViReTs)
por: Gálvez, Cristina, et al.
Publicado: (2022)

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab
por: Stüven, Anna Kathrin, et al.
Publicado: (2019)

Prolonged remission with pembrolizumab and radiation therapy in a patient with multisystem Langerhans cell sarcoma
por: Zanwar, Saurabh, et al.
Publicado: (2022)

Incidence of Recurrent High-Grade Anal Dysplasia in HIV-1-Infected Men and Women Following Infrared Coagulation Ablation: A Retrospective Cohort Study
por: Corral, Javier, et al.
Publicado: (2021)

SUN-LB097 Thyroid Hormone Resistance Simulating Graves Disease
por: Ballestas-Revollo, Martha, et al.
Publicado: (2019)

Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports
por: Gohara, Kazuki, et al.
Publicado: (2021)

Extremely low viral reservoir in treated chronically HIV-1-infected individuals
por: Gálvez, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_40bu9dlqacr32c4ra2badq37vi